Sehmi R, Cromwell O, Taylor G W, Kay A B
Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, UK.
J Immunol. 1991 Oct 1;147(7):2276-83.
We have purified and characterized the guinea pig eosinophil chemotactic factor of anaphylaxis (ECF-A), an activity previously described in diffusates from sensitized lung challenged with specific Ag that appeared to selectively attract eosinophils from mixed leukocyte populations. Time course studies showed that the release of ECF-A from challenged presensitized guinea pig lung fragments closely paralleled the release of immunoreactive leukotriene B4 (iLTB4) and histamine. However, the majority of ECF-A (greater than 80%) and iLTB4 (greater than 79%) was extractable with the lipid fraction from the methanol wash of Sep-Pak-extracted diffusate, whereas histamine remained in the aqueous phase. A comparable neutrophil chemotactic activity was also found in the methanol extracts of the anaphylactic diffusates. By using a combination of HPLC and specific RIA, greater than 60% of ECF-A was attributable to LTB4. A second eosinophil chemotactic activity was also identified and coeluted (on both reverse phase and straight phase HPLC) with the synthetic standard 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)eicosatetraenoic acid (8(S),15(S)-diHETE). This was confirmed as 8(S),15(S)-diHETE by gas chromatography-mass spectrometry. Platelet-activating factor and histamine had negligible activity for guinea pig eosinophils, compared with synthetic LTB4 (p less than 0.05, 10(-9) and 10(-8) M; p less than 0.01, 10(-7) to 5 x 10(-6) M). In addition, synthetic 8(S),15(S)-diHETE had 3 times less activity than LTB4 at optimal chemotactic concentrations (10(-6) and 10(-7) M, respectively). Thus, guinea pig ECF-A appears to be largely attributable to lipoxygenase products of arachidonic acid, namely LTB4 and 8(S),15(S)-diHETE. Because guinea pig ECF-A was equally active on neutrophils (greater than 96% purity), it can no longer be considered a selective eosinophil chemoattractant.
我们已经纯化并鉴定了豚鼠过敏反应性嗜酸性粒细胞趋化因子(ECF-A),该活性先前在经特异性抗原攻击的致敏肺脏的扩散物中有所描述,似乎能从混合白细胞群体中选择性吸引嗜酸性粒细胞。时间进程研究表明,受攻击的致敏豚鼠肺组织碎片中ECF-A的释放与免疫反应性白三烯B4(iLTB4)和组胺的释放密切平行。然而,大部分ECF-A(大于80%)和iLTB4(大于79%)可从Sep-Pak提取的扩散物甲醇洗脱液的脂质部分中提取出来,而组胺则保留在水相中。在过敏反应扩散物的甲醇提取物中也发现了类似的中性粒细胞趋化活性。通过结合高效液相色谱(HPLC)和特异性放射免疫分析(RIA),超过60%的ECF-A可归因于白三烯B4。还鉴定出了第二种嗜酸性粒细胞趋化活性,它与合成标准品8(S),15(S)-二羟基-5,9,11,13(Z,E,Z,E)二十碳四烯酸(8(S),15(S)-二HETE)在反相和正相HPLC上共洗脱。通过气相色谱-质谱法证实这就是8(S),15(S)-二HETE。与合成白三烯B4相比,血小板活化因子和组胺对豚鼠嗜酸性粒细胞的活性可忽略不计(10^(-9)和10^(-8) M时,p小于0.05;10^(-7)至5×10^(-6) M时,p小于0.01)。此外,在最佳趋化浓度(分别为10^(-6)和10^(-7) M)下,合成的8(S),15(S)-二HETE的活性比白三烯B4低3倍。因此,豚鼠ECF-A似乎在很大程度上归因于花生四烯酸的脂氧合酶产物,即白三烯B4和8(S),15(S)-二HETE。由于豚鼠ECF-A对中性粒细胞(纯度大于96%)同样有活性,它不能再被视为一种选择性嗜酸性粒细胞趋化剂。